Navigation Links
Kantar Health to Highlight Strategies for Accessing U.S. and EU Markets for Japan Pharma

New York NY (PRWEB) October 28, 2013

Kantar Health, a leading global healthcare consulting firm, and Synix will host a seminar, “The Keys to Market Access Success in the U.S. and European Markets,” on November 14 in Tokyo.

Changes in the healthcare system in the U.S. and Europe have a significant impact on the process of introducing new pharmaceutical agents, particularly high-cost specialty drugs such as oncolytics, to these markets. The importance of evaluating benefit assessments from the viewpoint of various stakeholders, such as patients, physicians and insurers, is rapidly rising. This seminar ? led by Gordon Gochenauer, Director, Commercial Planning (U.S.), and Andrew Miniuks, Senior Director, Commercial Planning (Europe) ? will cover:

  • U.S. and European Healthcare Systems: Do patients have access to the needed treatments and medications?
  • Pricing and Reimbursement: Will the drugs be reimbursed by insurance?
  • Stakeholder Relationships: How should pharmaceutical companies build relationships with stakeholders?
  • Case Studies in Oncology: Recent pricing, reimbursement and coverage decisions that highlight similarities and differences between the U.S. and Europe

The seminar will begin at 1 pm. Visit Synix’s website to register for this event ( or contact Gen Okamoto at market.assessment(at)synix(dot)co(dot)jp for more information.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Kantar Health to Highlight Role of Patient-Reported Outcomes in Russia
2. New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015
3. Biologic Treatment of Rheumatoid Arthritis Is Low in Brazil, According to Kantar Health Research
4. Treatment Rates of Prevalent Chronic Conditions Are Low in Brazil, According to Kantar Health Research
5. Kantar Health Americas CEO Mike Kelly Named to PharmaVOICE 100 for 2013
6. Kantar Health Launches CancerMPact Biomarker Analysis
7. Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
8. Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
9. Kantar Health to Present at PBIRG Annual General Meeting
10. AACR honors Hagop Kantarjian for outstanding clinical research
11. Kantar Health to Participate in CIO Summit of America Conference
Post Your Comments:
(Date:6/27/2016)... ... 27, 2016 , ... recently awarded their highest five-star rating to Best ... individuals in the United States and Canada wear eyeglasses. Once considered to be a ... and make a fashion statement. Even celebrities use glasses as a way of creating ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Pixel Film Studios ... X. , "Film editors can give their videos a whole new perspective by using ... - CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  Guerbet announced today that ... Supplier Horizon Award . One of ... was recognized for its support of Premier members through ... clinical excellence, and commitment to lower costs. ... this recognition of our outstanding customer service from Premier," ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Volumes: Global Analysis (United States, China, Japan, Brazil, United ... to their offering. ... healthcare business planners, provides surgical procedure volume data in ... with an in-depth analysis of growth drivers and inhibitors, ...
(Date:6/23/2016)... 2016 The Biotechnology industry might ... present great opportunities to investors. assesses the recent ... (NYSE: XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... receive your complimentary trade alerts at: ...
Breaking Medicine Technology: